"The non-exclusive patent licensing agreement with Takeda is part of our continuous efforts to make innovative medicines available to patients in India through strategic collaborations to meet unmet needs and enhance standard of care," Dr Reddy's CEO - Branded Markets (India & Emerging Markets) MV Ramana stated.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/qDIKMkL
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment